secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001558370-24-009211
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path gets Nasdaq extension to Sept 8 to meet $2.5M equity rule
------------------------------------------------------------------

- Non-compliance with Nasdaq minimum stockholders' equity of $2.5M noted March 12, 2024.
- Compliance plan submitted April 26, 2024; extension granted June 12, 2024 through Sept 8, 2024.
- If not compliant by Sept 8, delisting subject to appeal to Nasdaq Hearings Panel.
- Company intends to pursue compliance but no assurance of success or appeal outcome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000155837024009211/0001558370-24-009211-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000155837024009211/bpth-20240612x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009211

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer